Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL/6J mice

There is currently no established treatment for non-alcoholic fatty liver disease (NAFLD), including its most extreme form, non-alcoholic steatohepatitis (NASH). Ezetimibe, an inhibitor of Niemann-Pick C1 Like 1-dependent cholesterol absorption, improves diet-induced hyperlipidemia and attenuates li...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, XIANG, REN, QIAOHUA, WU, TAO, GUO, YONG, LIANG, YONG, LIU, SUBO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227427/
https://www.ncbi.nlm.nih.gov/pubmed/25310357
http://dx.doi.org/10.3892/mmr.2014.2623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227427/
https://www.ncbi.nlm.nih.gov/pubmed/25310357
http://dx.doi.org/10.3892/mmr.2014.2623

Ejemplares similares